Open study with ( −)‐OSU6162 in multiple sclerosis‐related fatigue

ConclusionsIn view of its good tolerability, ( −)‐OSU6162 may offer a new treatment option for alleviating mental fatigue, as well as depression, in MS. Larger, randomized double‐blind controlled trials are warranted to confirm the present preliminary observations.

Source: Acta Neurologica Scandinavica - November 4, 2018 Category: Neurology Authors: Sara Haghighi, Sara Forsmark, Arvid Carlsson, Marie K. L. Nilsson, Maria L. Carlsson, Robert C. Schuit, Carl ‐Gerhard Gottfries Tags: ORIGINAL ARTICLE Source Type: research